Arzu Umar
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer.
Journal: Scientific reports
Published: September 29, 2016
Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformation.
Journal: Proteomics
Published: May 16, 2016
Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera.
Journal: Journal of proteome research
Published: March 10, 2016
Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.
Journal: Drug discovery today
Published: February 15, 2016
Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients.
Journal: Scientific reports
Published: February 09, 2016
Global proteomic characterization of microdissected estrogen receptor positive breast tumors.
Journal: Data in brief
Published: September 14, 2015
4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.
Journal: Molecular oncology
Published: June 30, 2015
Antibody-based capture of target peptides in multiple reaction monitoring experiments.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 05, 2015
Shotgun proteomics on tissue specimens extracted with Acid guanidinium-thiocyanate-phenol-chloroform.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: June 05, 2015
Integrative analysis of genomics and proteomics data on clinical breast cancer tissue specimens extracted with acid guanidinium thiocyanate-phenol-chloroform.
Journal: Journal of proteome research
Published: January 23, 2015
Last Updated: 09/26/2026